Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial
Titel:
Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial
Auteur:
Leonetti, Alessandro Minari, Roberta Boni, Luca Gnetti, Letizia Verzè, Michela Ventura, Luigi Musini, Luca Tognetto, Michele Tiseo, Marcello